Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

NCT01269853 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme
Anaplastic Astrocytoma

Interventions

DRUG: Bevacizumab
DRUG: Bevacizumab

Sponsor

Northwell Health

Collaborators

[object Object]